×

Amicus Therapeutics CEO: Trump constructive for our industry

4:52 PM ET Wed, 1 March 2017

John Crowley, Amicus Therapeutics CEO, discusses the slowdown of the company's Galafold launch, FDA regulation and outlook under President Trump.